These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31779293)

  • 1. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Kohler JC; Bowra A
    Global Health; 2020 Oct; 16(1):101. PubMed ID: 33081805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Kohler JC
    Int J Health Policy Manag; 2019 Sep; 8(9):563-566. PubMed ID: 31657180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Vian T
    Int J Health Policy Manag; 2019 Aug; 8(8):505-507. PubMed ID: 31441292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corruption in global health: the open secret.
    García PJ
    Lancet; 2019 Dec; 394(10214):2119-2124. PubMed ID: 31785827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of anti-corruption and health in international organizations.
    Bowra A; Saeed G; Gorodensky A; Kohler JC
    PLoS One; 2022; 17(8):e0269203. PubMed ID: 35917329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successes and challenges of health systems governance towards universal health coverage and global health security: a narrative review and synthesis of the literature.
    Debie A; Khatri RB; Assefa Y
    Health Res Policy Syst; 2022 May; 20(1):50. PubMed ID: 35501898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corruption in Health Systems: The Conversation Has Started, Now Time to Continue it Comment on "We Need to Talk About Corruption in Health Systems".
    Lu HS; Ho BX; Miranda JJ
    Int J Health Policy Manag; 2020 Mar; 9(3):128-132. PubMed ID: 32202098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the Conversation, Why We Need to Reframe Corruption as a Public Health Issue Comment on "We Need to Talk About Corruption in Health Systems".
    Clarke D
    Int J Health Policy Manag; 2020 Jun; 9(6):257-259. PubMed ID: 32613794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of a global right to health norm--the unresolved case of universal access to quality emergency obstetric care.
    Hammonds R; Ooms G
    BMC Int Health Hum Rights; 2014 Feb; 14():4. PubMed ID: 24576008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for the Right to Health in the Sustainable Development Agenda Comment on "Rights Language in the Sustainable Development Agenda: Has Right to Health Discourse and Norms Shaped Health Goals?".
    Hawkes S; Buse K
    Int J Health Policy Manag; 2016 Feb; 5(5):337-9. PubMed ID: 27239885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All It Takes for Corruption in Health Systems to Triumph, Is Good People Who Do Nothing Comment on "We Need to Talk About Corruption in Health Systems".
    Mostert S; Kaspers G
    Int J Health Policy Manag; 2019 Oct; 8(10):610-612. PubMed ID: 31657188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health policy brief: Global mental health and the United Nations' sustainable development goals.
    Cratsley K; Mackey TK
    Fam Syst Health; 2018 Jun; 36(2):225-229. PubMed ID: 29369647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demystify False Dilemmas to Speak About Corruption in Health Systems: Different Actors, Different Perspectives, Different Strategies Comment on "We Need to Talk About Corruption in Health Systems".
    Hussmann K
    Int J Health Policy Manag; 2019 Oct; 8(10):620-622. PubMed ID: 31657191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Our Blind Spots in the Fight Against Health Systems Corruption Comment on "We Need to Talk About Corruption in Health Systems".
    Huss R
    Int J Health Policy Manag; 2020 Jan; 9(1):34-38. PubMed ID: 31902193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.